Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
clinical video

Indian Pediatr 2018;55:169

Recurrent UTI – Make the Child Smile!


*Rajiv Sinha1, Nayan Banerji2 and Subhasis Saha2

1Institute of Child Health and 2AMRI Hospital, Kolkata, India.
Email: [email protected]


 

An 8-year-old girl presented with history of recurrent urinary tract infection (UTI) along with episodes of urinary and fecal incontinence. Investigations revealed elevated creatinine (1.2 mg/dL, estimated glomerular-filtration rate (eGFR) = 42 mL/min/1.73 m2), bilateral hydronephrotic scarred kidneys with grade IV dilating vesico-ureteric reflux (VUR), and thickened urinary bladder wall. Urodynamic study confirmed a low capacity, high pressure urinary bladder with detrussor over activity. Neurological examination and magnetic resonance imaging of spine was un-remarkable. The diagnosis was clinched on seeing her typical facial expression on being asked to smile (Fig. 1 and Web Video 1).

Fig. 1 Characteristic facial expression on asking to smile (See video at website).

Ochoa syndrome or Urofacial syndrome (UFS) is characterized by urinary bladder or/and bowel dysfunction along with a characteristic facial expression that is most obvious during smiling or laughing wherein one gets an appearance of a ‘grimace’ despite an attempt at smiling (resulting from abnormal co-contraction of the corners of the mouth and eyes). It is inherited as autosomal recessive disorder with abnormalities in either of two genes – HPSE2 localized on chromosome 10q23-10q24 or LRIG localized on chromosome 1p13. A heterozygous nonsense variation in exon 4 of the LRIG2 gene (chr1:113636129; C>C/G; Depth: 121x) that results in a stop codon and premature truncation of the protein at codon 153 (p.Ser153Ter; ENST00000361127) was detected in the child by Next Generation Sequencing.

Apart from early identification and prompt treatment of urinary tract infection, the cornerstone of management of Ochoa syndrome includes reducing the bladder pressure and ensuring proper bladder drainage. Anti-cholinergics and á–adrenergic blockers along with clean intermittent catheterization are usually the initial steps. Bladder augmentation (augmentation cystoplasty) along with Mitrofanof (bladder drainage conduit) is often chosen as a long-term management plan.


 

Copyright © 1999-2018 Indian Pediatricsfont>